Shuke Ge*, Dan Wang†, Qinglong Kong‡, Wei Gao*, Jiayi Sun*
Oncology Research, Vol.25, No.8, pp. 1363-1371, 2017, DOI:10.3727/096504017X14878536973557
Abstract miR-152, as a tumor suppressor, has been reported to be downregulated in a number of cancer cell lines and
tumor tissues, including breast cancer. This study aimed to investigate the role of miR-152 in human breast
cancer and its underlying mechanisms. Human breast cancer cell line HCC1806 was transfected with hsa-miR-
152-3p mimic, inhibitor, or scrambled negative controls. The efficiency of miR-152-3p transfection was evaluated by quantitative real-time PCR, and the effects on cell viability and apoptosis as well as on the PI3K/AKT
signaling pathway were investigated by MTT assay, flow cytometry, and Western blot… More >